313 related articles for article (PubMed ID: 31828868)
41. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
42. microRNAs as biomarkers of ovarian cancer.
Zhang H; Lu B
Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
[No Abstract] [Full Text] [Related]
43. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
[TBL] [Abstract][Full Text] [Related]
44. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
45. Exosomes and cancer: From oncogenic roles to therapeutic applications.
Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
[TBL] [Abstract][Full Text] [Related]
46. Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Ria R; Vacca A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963513
[TBL] [Abstract][Full Text] [Related]
47. Tumor-derived extracellular vesicles and microRNAs: Functional roles, diagnostic, prognostic and therapeutic options.
Pontecorvi G; Bellenghi M; Puglisi R; Carè A; Mattia G
Cytokine Growth Factor Rev; 2020 Feb; 51():75-83. PubMed ID: 31924512
[TBL] [Abstract][Full Text] [Related]
48. Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.
Ji Z; Su J; Wu D; Peng H; Zhao W; Nlong Zhao B; Zhou X
Oncotarget; 2017 Jan; 8(5):7647-7665. PubMed ID: 28032590
[TBL] [Abstract][Full Text] [Related]
49. [Role of Exosomal miRNA in Multiple Myeloma Progression and Its Possible Mechanism -Review].
Yang YZ; Zhang XY; Wan Q; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):301-305. PubMed ID: 28245421
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
51. Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy.
Iranifar E; Seresht BM; Momeni F; Fadaei E; Mehr MH; Ebrahimi Z; Rahmati M; Kharazinejad E; Mirzaei H
J Cell Physiol; 2019 Mar; 234(3):2296-2305. PubMed ID: 30191975
[TBL] [Abstract][Full Text] [Related]
52. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
[TBL] [Abstract][Full Text] [Related]
53. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
Fanini F; Fabbri M
Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA and Exosome in Retinal-related Diseases: Their Roles in the Pathogenesis and Diagnosis.
Salmaninejad A; Pourali G; Shahini A; Darabi H; Azhdari S
Comb Chem High Throughput Screen; 2022; 25(2):211-228. PubMed ID: 33390101
[TBL] [Abstract][Full Text] [Related]
55. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma.
Allegra A; Ettari R; Innao V; Bitto A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672466
[TBL] [Abstract][Full Text] [Related]
56. The potential diagnostic power of extracellular vesicle analysis for multiple myeloma.
Canella A; Harshman SW; Radomska HS; Freitas MA; Pichiorri F
Expert Rev Mol Diagn; 2016; 16(3):277-84. PubMed ID: 26671731
[TBL] [Abstract][Full Text] [Related]
57. Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment.
Botta C; Cuce M; Caracciolo D; Fiorillo L; Tagliaferri P; Tassone P
Curr Cancer Drug Targets; 2017; 17(9):819-838. PubMed ID: 28359248
[TBL] [Abstract][Full Text] [Related]
58. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.
Soliman AM; Lin TS; Mahakkanukrauh P; Das S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066062
[TBL] [Abstract][Full Text] [Related]
59. New approaches to targeting the bone marrow microenvironment in multiple myeloma.
Gooding S; Edwards CM
Curr Opin Pharmacol; 2016 Jun; 28():43-9. PubMed ID: 27018230
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches.
Rossi M; Amodio N; Di Martino MT; Tagliaferri P; Tassone P; Cho WC
Curr Pharm Biotechnol; 2014; 15(5):459-67. PubMed ID: 24846067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
